Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 3.14%40.61K | 13.69%44K | -5.61%158.34K | -10.59%40.37K | -8.66%39.88K | -3.57%39.37K | 1.58%38.71K | -23.22%167.75K | -45.88%45.15K | -32.08%43.66K |
| Gross profit | -3.14%-40.61K | -13.69%-44K | 5.61%-158.34K | 10.59%-40.37K | 8.66%-39.88K | 3.57%-39.37K | -1.58%-38.71K | 23.22%-167.75K | 45.88%-45.15K | 32.08%-43.66K |
| Operating expense | 19.96%493.89K | 3.81%381.64K | -27.97%1.46M | -34.90%363.51K | -32.14%312.92K | -23.31%411.73K | -20.78%367.64K | -15.21%2.02M | -7.85%558.38K | -30.57%461.13K |
| Selling and administrative expenses | 16.69%398.02K | -4.32%297.69K | -31.42%1.19M | -41.80%290.08K | -31.86%249.45K | -25.73%341.08K | -24.74%311.15K | -14.66%1.74M | -8.66%498.39K | -34.86%366.1K |
| -Selling and marketing expense | 207.71%58.13K | 94.65%42.24K | -43.31%79.89K | -27.99%25.13K | -35.39%14.17K | -24.48%18.89K | -63.27%21.7K | 58.41%140.93K | 77.75%34.9K | -24.99%21.93K |
| -General and administrative expense | 5.49%339.89K | -11.75%255.45K | -30.37%1.11M | -42.84%264.95K | -31.64%235.29K | -25.80%322.19K | -18.32%289.45K | -18.00%1.6M | -11.88%463.49K | -35.41%344.17K |
| Other operating expenses | 35.70%95.87K | 48.60%83.95K | -6.80%264.04K | 22.41%73.43K | -33.21%63.47K | -9.02%70.65K | 11.55%56.49K | -18.42%283.32K | -0.53%59.99K | -6.97%95.04K |
| Operating profit | -18.49%-534.5K | -4.75%-425.64K | 26.26%-1.61M | 33.08%-403.89K | 30.11%-352.81K | 21.91%-451.1K | 19.08%-406.34K | 15.88%-2.19M | 12.45%-603.53K | 30.71%-504.79K |
| Net non-operating interest income (expenses) | -104.52%-419 | -121.21%-2.6K | -87.74%28.17K | -94.59%1.43K | -90.59%5.2K | -85.81%9.28K | -85.18%12.27K | -6.06%229.77K | -72.95%26.4K | -45.31%55.22K |
| Non-operating interest income | -74.94%3.27K | -91.35%1.41K | -82.48%43.56K | -82.51%5.49K | -85.43%8.66K | -81.35%13.06K | -81.37%16.35K | -5.69%248.62K | -69.76%31.39K | -43.50%59.45K |
| Non-operating interest expense | -2.51%3.69K | -1.62%4.02K | -18.34%15.39K | -18.64%4.06K | -18.08%3.46K | -18.59%3.79K | -18.03%4.08K | -0.99%18.85K | -19.63%4.99K | -0.38%4.23K |
| Other net income (expenses) | 41.41%200.36K | 305.86%157.11K | -1,309.76%-3.47M | -11,200.45%-4.06M | 5,877.35%527.41K | 185.93%141.69K | 29.72%-76.32K | -127.27%-246.03K | 904.28%36.59K | -101.79%-9.13K |
| Gain on sale of security | -117.89%-25.35K | 31.10%-77.22K | 246.56%303.3K | 434.01%193.43K | 913.11%80.25K | 213.62%141.69K | -3.19%-112.07K | -119.23%-206.95K | -77.58%36.22K | -101.87%-9.87K |
| Special income (charges) | --109 | --20.68K | -10,821.13%-4.27M | -1,172,621.43%-4.27M | --0 | --0 | --0 | 77.51%-39.08K | 100.23%364 | 104.67%741 |
| -Less:Impairment of capital assets | --0 | ---28.57K | 10,821.13%4.27M | 1,172,621.43%4.27M | --0 | --0 | --0 | -77.51%39.08K | -100.23%-364 | -104.67%-741 |
| -Gain on sale of property,plant,equipment | --109 | ---7.89K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 7,519,800.00%225.6K | 497.66%213.65K | --496.25K | --13.34K | --447.16K | --3 | --35.75K | ---- | ---- | ---- |
| Income before tax | -11.47%-334.56K | 42.36%-271.13K | -129.26%-5.05M | -725.77%-4.46M | 139.20%179.81K | 55.68%-300.14K | 10.91%-470.4K | -51.57%-2.2M | 8.09%-540.55K | -292.29%-458.7K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -11.47%-334.56K | 42.36%-271.13K | -129.26%-5.05M | -725.77%-4.46M | 139.20%179.81K | 55.68%-300.14K | 10.91%-470.4K | -51.57%-2.2M | 8.09%-540.55K | -292.29%-458.7K |
| Net income continuous operations | -11.47%-334.56K | 42.36%-271.13K | -129.26%-5.05M | -725.77%-4.46M | 139.20%179.81K | 55.68%-300.14K | 10.91%-470.4K | -51.57%-2.2M | 8.09%-540.55K | -292.29%-458.7K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -11.47%-334.56K | 42.36%-271.13K | -129.26%-5.05M | -725.77%-4.46M | 139.20%179.81K | 55.68%-300.14K | 10.91%-470.4K | -51.57%-2.2M | 8.09%-540.55K | -292.29%-458.7K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -11.47%-334.56K | 42.36%-271.13K | -129.26%-5.05M | -725.77%-4.46M | 139.20%179.81K | 55.68%-300.14K | 10.91%-470.4K | -51.57%-2.2M | 8.09%-540.55K | -292.29%-458.7K |
| Diluted earnings per share | 0 | 0 | -133.33%-0.07 | -500.00%-0.06 | 0 | 0 | 0.00%-0.01 | -50.00%-0.03 | 0.00%-0.01 | -518.81%-0.01 |
| Basic earnings per share | 0 | 0 | -133.33%-0.07 | -500.00%-0.06 | 0 | 0 | 0.00%-0.01 | -50.00%-0.03 | 0.00%-0.01 | -518.81%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.